Find your patients 40x more personalized treatment options

We analyze 100,000s of peer-reviewed papers to identify the best treatment options specific to your patient's profile, giving you the confidence to move forward with their treatment

Thank you. A member of our team will reach out to you shortly.

Oops! Something went wrong while submitting the form.

"In today's world of personalized cancer therapy it's important to understand the genetic and metabolic fingerprint of each tumour in order to determine the most appropriate combinations of drugs"

Dr Andrew Gaya

Consultant Clinical Oncologist at the Cromwell Hospital

"Astron's evidence-based innovation..... could rapidly become a transformative approach to oncology"

Dr Ndaba Mazibuko

Research Fellow at Kings College London

Our team have led teams and studied at some of the world's top research organisations

How we target the drivers of cancer, tolerably

Molecular tests can identify 1000s of mutations, but conventional precision oncology only targets fewer than 50 of these, limiting its ability to target the drivers of cancer. Our bioinformatic drug repurposing research lets us match 40x more drivers than current precision oncology. Our treatment recommendations are peer reviewed, well understood and highly tolerable, so they are well suited for use in remission, recurrence or progression.

How Astron Works

Molecular Analysis

We conduct testing to identify the identify the unique drivers of your patient's cancer.

Targeted Treatment Planning

We analyze over 100,000s of peer-reviewed papers to match the best repurposed drugs and supplement to these drivers using advanced scientific research.

Report Generation

We generate a research report tailored to your patient's profile, giving you the clear scientific rationale and evidence-backed research.

Protocol Creation

You can then use our report to create a truly personalized treatment protocol that targets your patient's unique vulnerabilities

When can you use Astron in your practice?

After curative treatment

Find the unique drivers of your patient's and use a focused, evidence-based approach from the start.

After any cycle of treatment

Identify research that may help your patient delay or prevent recurrence and stabilize the disease after a cycle of treatment.

After imaging or symptom progression

Find the evidence to personalized therapies for your patients based on tumor evolution and emerging resistance mechanisms.

Upon confirmation of cancer

Identify options for your patients that may help maintain equilibrium or slow down aggresive progression.

Why partner with Astron?

Maximize curative treatment cycles for each patient

Save time on personalized research for your patients

Co-authoring opportunities for peer reviewed publications

AI-driven treatment insights based on real-world data

Personalized evidence-based treatment options for patients at every stage of their treatment journey

Get more patients by offering precision oncology services

Peace of mind for your patients

What patients are saying about Astron

"With these treatments I've got optionality and that makes a huge difference psychologically"

Paul

Astron Patient

"Practically tackling issues specific to my cancer has quite simply been life changing"

Judith

Astron Patient

"I've taken control in some way, you know. I want to know I've ticked every box."

Carol

Astron Patient

Current Clinical Research

An observational study evaluating longitudinal Minimal Residual Disease (MRD) status in potentially curable Pancreatic Ductal Adenocarcinoma (PDAC) following definitive treatment.

Get your practice involved in co-authoring our ground breaking clinical study or clinical registry study at the forefront of precision oncology.

Learn More